The Diagnostic Utility of Natural Killer Cell Subsets in Deep Vein Thrombosis

References

• Geersing GJ, Cazemier S, Rutten F, Fitzmaurice DA, Hoes AW. Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands. BMJ Open. 2018;8(4):e019967. PMID: 29678975; PMCID: PMC5914716. doi:10.1136/bmjopen-2017-019967
   PubMed Web of Science ®Google Scholar
• Ruppert A, Lees M, Steinle T. Clinical burden of venous thromboembolism. Curr Med Res Opin. 2010;26(10):2465–2473. PMID: 20825270. doi:10.1185/03007995.2010.516090
   PubMed Web of Science ®Google Scholar
• Lee LH, Gallus A, Jindal R, Wang C, Wu CC. Incidence of venous thromboembolism in asian populations: a systematic review. Throm Haemo. 2017;117(12):2243–2260. PMID: 29212112. doi:10.1160/TH17-02-0134
   PubMed Web of Science ®Google Scholar
• van Montfoort ML, Stephan F, Lauw MN, et al. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arter Throm Vas Biol. 2013;33(1):147–151. PMID: 23104849. doi:10.1161/ATVBAHA.112.300498
   PubMed Web of Science ®Google Scholar
• von Brühl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819–835. PMID: 22451716; PMCID: PMC3328366. doi:10.1084/jem.20112322
   PubMed Web of Science ®Google Scholar
• Kambas K, Mitroulis I, Apostolidou E, et al. Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS One. 2012;7(9):e45427. PMID: 23029002; PMCID: PMC3446899. doi:10.1371/journal.pone.0045427
   PubMed Web of Science ®Google Scholar
• Brill A, Fuchs TA, Savchenko AS, et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Throm Haemo. 2012;10(1):136–144. PMID: 22044575; PMCID: PMC3319651. doi:10.1111/j.1538-7836.2011.04544.x
   PubMed Web of Science ®Google Scholar
• Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med. 2017;23(3):279–287. PMID: 28267716. doi:10.1038/nm.4294
   PubMed Web of Science ®Google Scholar
• Artis D, Spits H. The biology of innate lymphoid cells. Nature. 2015;517(7534):293–301. doi:10.1038/nature14189
   PubMed Web of Science ®Google Scholar
• Vivier E, Raulet DH, Moretta A, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331(6013):44–49. PMID: 21212348; PMCID: PMC3089969. doi:10.1126/science.1198687
   PubMed Web of Science ®Google Scholar
• Bertin FR, Rys RN, Mathieu C, Laurance S, Lemarié CA, Blostein MD. Natural killer cells induce neutrophil extracellular trap formation in venous thrombosis. J Throm Haemo. 2019;17(2):403–414. PMID: 30456926. doi:10.1111/jth.14339
   PubMed Web of Science ®Google Scholar
• Qaseem A, Snow V, Barry P, et al. Joint American Academy of family physicians/American college of physicians panel on deep venous thrombosis/pulmonary embolism. current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of family physicians and the American college of physicians. Ann Fam Med. 2007;5(1):57–62. PMID: 17261865; PMCID: PMC1783928. doi:10.1370/afm.667
   PubMed Web of Science ®Google Scholar
• Scoville SD, Freud AG, Caligiuri MA. Modeling human natural killer cell development in the era of innate lymphoid cells. Front Immunol. 2017;8:360. PMID: 28396671; PMCID: PMC5366880. doi:10.3389/fimmu.2017.00360
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trend Immunol. 2001;22(11):633–640. PMID: 11698225. doi:10.1016/s1471-4906(01)02060-9
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001;97(10):3146–3151. PMID: 11342442. doi:10.1182/blood.v97.10.3146
   PubMed Web of Science ®Google Scholar
• Mikulak J, Di Vito C, Zaghi E, Mavilio D. Host immune responses in HIV-1 infection: the emerging pathogenic role of siglecs and their clinical correlates. Front Immunol. 2017;8:314. PMID: 28386256; PMCID: PMC5362603. doi:10.3389/fimmu.2017.00314
   PubMedGoogle Scholar
• Dulphy N, Haas P, Busson M, et al. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J Immunol. 2008;181(3):2227–2237. PMID: 18641363. doi:10.4049/jimmunol.181.3.2227
   PubMed Web of Science ®Google Scholar
• Duan Q, Gong Z, Song H, et al. Symptomatic venous thromboembolism is a disease related to infection and immune dysfunction. Int J Med Sci. 2012;9(6):453–461. PMID: 22859906; PMCID: PMC3410365. doi:10.7150/ijms.4453
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang Q, Shen Y, Song H, Gong Z, Wang L. Compromised natural killer cells in pulmonary embolism. Int J Clin Exper Pathol. 2015;8(7):8244–8251. PMID: 26339393; PMCID: PMC4555721.
   PubMed Web of Science ®Google Scholar
• Thålin C, Daleskog M, Göransson SP, et al. Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma. Immun Res. 2017;65(3):706–712. PMID: 28161762; PMCID: PMC5440486. doi:10.1007/s12026-017-8905-3
   Google Scholar
• Liu L, Zhang W, Su Y, Chen Y, Cao X, Wu J. The impact of neutrophil extracellular traps on deep venous thrombosis in patients with traumatic fractures. Clin. Chim. Acta. 2021;519:231–238. PMID: 34015302. doi:10.1016/j.cca.2021.04.021
   PubMed Web of Science ®Google Scholar
• Mauracher LM, Posch F, Martinod K, et al. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients. J Throm Haemo. 2018;16(3):508–518. PMID: 29325226; PMCID: PMC6294121. doi:10.1111/jth.13951
   PubMed Web of Science ®Google Scholar